We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AZRG:TASEAzrieli Group Ltd. Analysis

Data as of 2026-03-11 - not real-time

ILA 47,040.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Azrieli Group Ltd. (AZRG.TA) is trading at 47,040 ILA, comfortably above its 20‑day SMA (46,455) and 50‑day SMA (43,402), indicating short‑term momentum, while the 30‑day volatility sits near 41%, suggesting price swings can be sizable. The RSI of 55.8 places the stock in a neutral zone, and the MACD shows a bearish histogram (‑46) with the line below its signal, hinting at potential downside pressure despite the bullish trend direction. Sentiment is extremely positive, reflected by a Fear & Greed Index of 77 (Extreme Greed), yet the upside/downside projection is –8.3%, implying limited upside ahead.
Fundamentally, the company commands a high P/E of 34.7 versus an industry average of 32.6 and an astronomically elevated P/B of 230, signaling that the market is pricing in strong growth expectations that may be hard to justify. Margins are solid (gross 68%, operating 57%), but free cash flow is negative (‑555 M) and debt‑to‑equity is steep at 119%, raising concerns about leverage and dividend sustainability, especially with a payout ratio of 48.8% and a modest 1.4% yield. Overall, the stock appears overvalued, with growth expectations outpacing cash generation, and investors should weigh the strong market momentum against the fundamental headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above 20‑day SMA supporting short‑term momentum
  • Bearish MACD histogram suggesting possible pullback
  • Increasing volume indicating active trading interest

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Overvaluation indicated by P/B of 230 and P/E above industry
  • High leverage (debt‑to‑equity 119%) and negative free cash flow
  • Stable dividend yield but sustainability concerns

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Fundamental overvaluation with limited upside potential
  • Elevated debt levels and cash flow deficits
  • Dividend sustainability risk amid weak cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth16.00%
Profit Margin43.66%
P/E Ratio34.7
ROE6.80%
ROA2.27%
Debt/Equity119.50
P/B Ratio230.3
Op. Cash FlowILA1.8B
Free Cash FlowILA-555000000
Industry P/E32.6

Technical Analysis

TrendBullish
RSI55.8
SupportILA 42,850.00
ResistanceILA 50,600.00
MA 20ILA 46,455.50
MA 50ILA 43,402.00
MA 200ILA 33,922.90
MACDBearish
VolumeIncreasing
Fear & Greed Index77.18

Valuation

Fair ValueILA 6,066.60
Target PriceILA 43,150.00
Upside/Downside-8.27%
GradeOvervalued
TypeBlend
Dividend Yield1.40%

Risk Assessment

Beta0.11
Volatility40.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.